Gann Support (EP/CL): 0.65/0.61 | Resistance (TP): 0.69/0.73
iGann Support (EP/CL): 0.65/0.63 | Resistance (TP): 0.7/0.72
*Highlighted column shows significant volume at the support or resistance area.
Moving Average Trend
Trading Signalsbeta - EIG
Based on iSaham Screeners
Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
BUY (Above 0)
Solid MA Trend
Sector Trend (Long Term)
Sector Trend (Short Term)
Beat The Insti
Better Than ASB
Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.
iSaham Fair Value: 0.275
Discounted Cash Flow (DCF)5.0% Growth
Discounted Cash Flow (DCF)-4.2% Growth
Net Tangible Asset MA
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
EIG is principally engaged in investment holding, whilst the principal activities of the subsidiaries are operating of skin care centers, importing and distributing of skin care products and beauty equipment. ESTETIC core business involves continuous skin care and body wellness consultations, conduct training for beautician and skin care therapies programmes. The company is also involved in the trading and sales of skin care products and beauty equipments. The main ranges of products are such as a range of Dermalogica skin care products, Averine cosmetics, Eve Taylor essential oils, Bioxil range of products and Nemectron equipments. ESTETIC also provides professional skin care services. ESTETIC owns the exclusive distributorship rights from Dermalogica Inc, USA for the distribution of a range of dermalogical products.